Clobetasol propionate, a highly potent topical corticosteroid used in the treatment of inflammatory skin disorders such as psoriasis and eczema, was developed in the 1970s and introduced into medical use as part of a new generation of high-potency dermatologic therapies. Its history is marked by strong clinical effectiveness in rapidly reducing inflammation, itching, and plaque formation, particularly in resistant dermatoses, which led to its widespread adoption in dermatology.
BRAND NAMES
Clobetasol propionate is sold under several brand names worldwide, depending on the country and formulation (cream, ointment, scalp solution, shampoo, foam, etc.).
Common brand names include:
MECHANISM OF ACTION
Clobetasol propionate is a very potent topical corticosteroid that works by binding to glucocorticoid receptors in skin cells and altering gene expression to reduce inflammation. It suppresses the production of inflammatory mediators like prostaglandins and leukotrienes by inhibiting phospholipase A2 and decreasing cytokine release. This leads to reduced redness, swelling, itching, and immune activity in the affected skin areas.
PHARMACOKINETICS
Absorption
Clobetasol propionate is absorbed through the skin in small amounts, with absorption increasing in damaged or thin skin. Using it over large areas, for long periods, or under occlusion can increase systemic absorption and may lead to side effects like HPA axis suppression.
Distribution
For Clobetasol propionate, the volume of distribution (Vd) after topical use is not well defined/very low systemically, because only a small fraction enters systemic circulation.
Reported systemic Vd (approx., if absorbed): ~1–2 L/kg
Clinical relevance: minimal systemic distribution at normal topical doses
Metabolism
Clobetasol propionate is primarily metabolized in the liver after systemic absorption. It undergoes oxidation and reduction reactions, leading to inactive metabolites that are further conjugated and eliminated. Because only a small amount is absorbed through the skin under normal use, systemic metabolism is usually limited.
Elimination
Clobetasol propionate is eliminated mainly through hepatic metabolism followed by excretion of inactive metabolites in the urine and bile. Only a very small amount of unchanged drug is excreted. Its elimination is usually limited because systemic absorption from topical use is low under normal conditions.
PHARMACODYNAMICS
Penetrates skin cells and binds to glucocorticoid receptors in the cytoplasm
Drug–receptor complex moves into the cell nucleus
Modulates gene transcription (upregulates anti-inflammatory proteins, downregulates pro-inflammatory genes)
Inhibits release of inflammatory mediators like cytokines, prostaglandins, leukotrienes
Reduces migration and activity of immune cells (T cells, macrophages, eosinophils)
Final effect: reduced inflammation, itching, and skin immune response
ADMINISTRATION
Clobetasol propionate is applied topically to the affected skin or scalp in a thin layer, usually once or twice daily as prescribed. It is intended for short-term use only due to its high potency and should be used carefully to avoid over-application or use on large body areas.
DOSAGE AND STRENGTH
Clobetasol propionate is available in 0.05% strength in forms like cream, ointment, lotion, gel, foam, and shampoo. It is applied in a thin layer once or twice daily for short-term use, usually not exceeding two weeks or the recommended weekly amount to reduce the risk of side effects.
DRUG INTERACTIONS
Minimal interactions due to low topical systemic absorption
Increased risk when used with other corticosteroids (additive steroid effects)
CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase systemic steroid levels if absorption occurs
Occlusive dressings or damaged skin can increase absorption and interaction risk
Caution with long-term or high-dose use due to possible HPA axis suppression
FOOD INTERACTIONS
Clobetasol propionate has no clinically significant food interactions because it is applied topically and has minimal systemic absorption under normal use. However, if used extensively or over large areas, systemic absorption may increase slightly, but food intake still does not meaningfully affect its action or safety.
CONTRAINDICATIONS
Hypersensitivity to clobetasol or any formulation component
Untreated bacterial, viral, or fungal skin infections (e.g., herpes, varicella, tinea)
Rosacea and perioral dermatitis
Use on facial acne or acne vulgaris
Primary skin infections without appropriate antimicrobial therapy
SIDE EFFECTS
Skin thinning (atrophy)
Burning or stinging sensation
Itching or irritation
Dry skin
Stretch marks (striae)
OVER DOSE
Clobetasol propionate overdose is usually due to overuse or long-term application, leading to skin thinning and irritation, and in severe cases systemic effects like adrenal suppression
TOXICITY
Clobetasol propionate toxicity is usually due to overuse or long-term application and can cause skin thinning and irritation, and in severe cases systemic effects like adrenal suppression.